On Mar. 30, 2020, Bayer announced it had made available more than 40 virus diagnostics devices from its research operations, enabling Germany’s COVID-19 analysis capacity to be increased by several thousand tests daily.

Bayer also freed up specially trained personnel for this purpose. At its Berlin campus, Bayer established a two-story testing laboratory, and in North Rhine-Westphalia, the company provided equipment to certified external testing laboratories.